Identification and Analysis of Estrogen Receptor α Promoting Tamoxifen Resistance-Related lncRNAs

70-75% breast cancer patients are estrogen receptor alpha positive (ERα+), and the antiestrogen drug tamoxifen has been used for the past three decades. However, in 20-30% of these patients, tamoxifen therapy fails due to intrinsic or acquired resistance. A previous study has showed ERα signaling st...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xiulei, Gao, Shanjun, Li, Zhen, Wang, Wei, Liu, Guangzhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7204353/
https://www.ncbi.nlm.nih.gov/pubmed/32420379
http://dx.doi.org/10.1155/2020/9031723

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7204353/
https://www.ncbi.nlm.nih.gov/pubmed/32420379
http://dx.doi.org/10.1155/2020/9031723

Ejemplares similares